Chinese Journal of Chromatography ›› 2024, Vol. 42 ›› Issue (3): 234-244.DOI: 10.3724/SP.J.1123.2023.09015
• Articles • Previous Articles Next Articles
SHI Yuhao1,2, NAN Yi1,2, ZHENG Wei2, YAO Lan2, LIANG Haizhen2, CHEN Xiaojuan2, SONG Juan2, ZHANG Jie2, JIA Dexian3, WANG Qian3, MA Baiping1,2,*()
Received:
2023-09-18
Online:
2024-03-08
Published:
2024-03-19
Supported by:
CLC Number:
SHI Yuhao, NAN Yi, ZHENG Wei, YAO Lan, LIANG Haizhen, CHEN Xiaojuan, SONG Juan, ZHANG Jie, JIA Dexian, WANG Qian, MA Baiping. Qualitative and semiquantitative analyses of the chemical components of the seed coat and kernel of Ziziphi Spinosae Semen[J]. Chinese Journal of Chromatography, 2024, 42(3): 234-244.
Fig. 1 Base peak intensity (BPI) chromatograms of seed coat and kernel of Ziziphi Spinosae Semen in negative and positive ion modes by UPLC-Q-TOF/MSE analysis The peak numbers hereby are consistent with those in Table 1.
No. | tR in | Formula | Precursor ion | Mass | Theoretical mass | Error/ 10-6 | Fragment ions (m/z) | Compound | Seed coat | Seed kernel | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2.25 | C16H18O9 | [M-H]- | 353.0867 | 353.0873 | -1.7 | 335.0876, 191.0549, 179.0344, 161.0211, 135.0441 | neochlorogenic acid[ | + | + | |||||||||
2 | 3.30 | C16H18O9 | [M-H]- | 353.0870 | 353.0873 | -0.9 | 191.0550, 179.0347, 161.0232, 85.0329 | chlorogenic acid[ | + | + | |||||||||
3 | 3.52 | C16H18O9 | [M-H]- | 353.0869 | 353.0873 | -1.1 | 191.0557, 179.0339, 173.0450, 161.0248, 155.0330, 135.0444, | cryptochlorogenic acid[ | + | + | |||||||||
93.0338 | |||||||||||||||||||
4 | 3.67 | C19H24NO3 | [M]+ | 314.1760 | 314.1756 | 1.3 | 314.1755, 269.1203, 237.0095, 211.1090, 175.0743, 145.0653, | magnocurarine isomer[ | + | + | |||||||||
116.9765, 107.0503 | |||||||||||||||||||
5 | 4.26 | C17H19NO3 | [M+H]+ | 286.1447 | 286.1443 | 1.4 | 286.1440, 269.1181, 237.0911, 209.0965, 191.0856, 175.0756, | aconitine[ | + | + | |||||||||
143.0495, 107.0496 | |||||||||||||||||||
6 | 4.66 | C20H26NO4 | [M]+ | 344.1860 | 344.1862 | -0.6 | 299.1278, 267.0997, 239.1145, 237.0904, 207.9867, 175.0752, | tembetarin[ | + | + | |||||||||
137.0577 | |||||||||||||||||||
7 | 4.73 | C27H30O15 | [M-H]- | 593.1514 | 593.1506 | 1.4 | 473.1082, 395.0771, 383.0767, 353.0657, 325.0708, 297.0758 | vicenin-Ⅱ[ | + | + | |||||||||
8 | 4.84 | C20H24NO4 | [M]+ | 342.1703 | 342.1705 | -0.6 | 297.1129, 282.0894, 265.0867, 237.0914, 219.0803, 58.0668 | magnoflorineb | + | + | |||||||||
9 | 5.51 | C19H24NO3 | [M]+ | 314.1761 | 314.1756 | 1.6 | 314.1755, 269.1185, 237.0928, 209.0956, 175.0746, 143.0493 | magnocurarine[ | + | + | |||||||||
10 | 6.00 | C42H48O23 | [M+H]+ | 921.2681 | 921.2665 | 1.7 | 759.2183, 741.1762, 639.1682, 447.1330, 429.1185, 411.1058, | 6‴-(4‴-O-glc)-vanilloylspinosin[ | - | + | |||||||||
381.0920, 351.0924, 327.0807, 151.0363 | |||||||||||||||||||
11 | 6.08 | C27H30O15 | [M+H]+ | 595.1649 | 595.1663 | -2.4 | 433.1125, 415.1020, 397.0916, 379.0811, 367.0818, 337.0724, | meloside A[ | - | + | |||||||||
313.0710, 283.0609 | |||||||||||||||||||
12 | 6.29 | C32H38O19 | [M+H]+ | 727.2081 | 727.2086 | -0.7 | 595.1814, 581.1440, 449.1064, 287.0556 | camelliaside B[ | + | + | |||||||||
13 | 6.40 | C28H32O15 | [M+H]+ | 609.1804 | 609.1819 | -2.5 | 447.1285, 429.1191, 411.1051, 393.0976, 351.0873, 327.0871, | isospinosin[ | + | + | |||||||||
297.0765, 285.0767 | |||||||||||||||||||
14 | 6.49 | C28H32O15 | [M+H]+ | 609.1813 | 609.1819 | -1.0 | 489.1479, 447.1290, 429.1180, 411.1070, 393.1081, 381.0967, | spinosinb | + | + | |||||||||
351.0864, 327.0868, 297.0757 | |||||||||||||||||||
15 | 6.56 | C21H20O10 | [M-H]- | 431.0972 | 431.0978 | -1.4 | 323.0573, 311.0557, 307.0622, 293.0428, 283.0594, 281.0456, | isovitexin[ | + | + | |||||||||
269.0444 | |||||||||||||||||||
16 | 6.67 | C27H30O15 | [M-H]- | 593.1511 | 593.1506 | 0.8 | 593.1526, 285.0394 | kaempferol-3-O-rutoside isomer[ | + | + | |||||||||
17 | 6.73 | C29H36O15 | [M-H]- | 623.1985 | 623.1976 | 1.4 | 461.1664, 179.0341, 161.0236 | acteoside[ | + | + | |||||||||
18 | 6.81 | C29H36O15 | [M-H]- | 623.1982 | 623.1976 | 1.0 | 461.0904, 179.0342, 161.0236 | isoacteoside[ | + | + | |||||||||
19 | 6.87 | C22H22O10 | [M+H]+ | 447.1292 | 447.1291 | 0.2 | 429.1295, 411.1142, 327.0872, 297.0773, 174.0549 | swertisin[ | + | + | |||||||||
20 | 7.29 | C25H24O12 | [M-H]- | 515.1195 | 515.1190 | 1.0 | 353.0880, 191.0553, 179.0340, 173.0448, 135.0443 | isochlorogenic acid B[ | + | + | |||||||||
21 | 7.40 | C27H30O15 | [M-H]- | 593.1508 | 593.1506 | 0.3 | 285.0388, 284.0316, 255.0291 | kaempferol-3-O-rutoside[ | - | + | |||||||||
22 | 7.53 | C25H24O12 | [M-H]- | 515.1190 | 515.1190 | 0 | 353.0858, 191.0552, 179.0340, 173.0458, 135.0439 | isochlorogenic acid A[ | + | + | |||||||||
23 | 7.70 | C44H49O22N | [M+H]+ | 944.2816 | 944.2824 | -0.9 | 944.2839, 824.2661, 447.1273, 429.1159, 327.0866, 297.1133 | 6‴-O-(3-Glc-indole-acetyl)spinosin or isomer[ | - | + | |||||||||
24 | 7.75 | C37H38O18 | [M+H]+ | 771.2140 | 771.2136 | 0.5 | 651.1650, 609.1619, 433.1139, 415.1023, 379.0705, 337.0701, | isovitexin-2″-O-(6-feruloyl)-glucopyranoside[ | + | + | |||||||||
313.0726, 177.0555 | |||||||||||||||||||
25 | 7.82 | C44H49O22N | [M+H]+ | 944.2815 | 944.2824 | 0.1 | 944.2797, 824.2675, 447.1271, 429.1161, 411.1082, 327.0849, | 6‴-O-(3-Glc-indole-acetyl)spinosin or isomer[ | - | + | |||||||||
297.0788 | |||||||||||||||||||
26 | 8.15 | C25H24O12 | [M-H]- | 515.1185 | 515.1190 | -1.0 | 353.0862, 191.0551, 179.0338, 173.0447, 135.0443 | isochlorogenic acid C[ | + | + | |||||||||
27 | 8.18 | C39H42O19 | [M+H]+ | 815.2397 | 815.2399 | -0.3 | 695.2109, 609.1945, 447.1345, 429.1194, 411.1042, 393.0956, | 6‴-sinapoylspinosin[ | - | + | |||||||||
327.0868, 297.0854, 207.0659, 163.0387 | |||||||||||||||||||
28 | 8.20 | C43H52O19 | [M+H]+ | 873.3188 | 873.3181 | 0.8 | 855.3101, 735.2551, 447.1412, 429.1191, 411.1068, 393.0933, | 6‴-dihydrophaseoylspinosin[ | - | + | |||||||||
351.0852, 327.0861, 247.1341, 207.0649, 163.0397 | |||||||||||||||||||
29 | 8.30 | C37H38O17 | [M+H]+ | 755.2174 | 755.2187 | -1.7 | 635.1722, 609.1754, 447.1285, 429.1180, 351.0857, 327.0863, | 6‴-p-coumaloylspinosin[ | - | + | |||||||||
309.0979, 147.0442 | |||||||||||||||||||
30 | 8.39 | C38H40O18 | [M+H]+ | 785.2289 | 785.2293 | -0.5 | 665.1870, 609.1771, 447.1184, 429.1184, 411.1092, 393.0977, | 6‴-feruloylspinosinb | + | + | |||||||||
381.0981, 351.0871, 327.0869, 207.0765, 177.0551 | |||||||||||||||||||
31 | 8.74 | C44H49O22N | [M+H]+ | 944.2810 | 944.2824 | -1.5 | 944.2797, 782.2302, 764.2184, 489.1389, 393.0977, 327.0861 | 3‴-(N-β-D-Glucopyranosyl)-2‴,3‴-dihydro-2‴- | - | + | |||||||||
oxo-indol-3‴-yl-acetate spinosin or isomer[ | |||||||||||||||||||
32 | 8.84 | C44H49O22N | [M+H]+ | 944.2811 | 944.2824 | -1.4 | 944.2799, 782.2269, 764.2170, 602.1631, 489.1395, 393.0974, | 6‴-(N-β-D-glucopyranosyl)-2‴,3‴-dihydro-2‴- | - | + | |||||||||
327.0861 | oxo-indol-3‴-yl-acetate spinosin or isomer[ | ||||||||||||||||||
33 | 9.37 | C18H19NO2 | [M+H]+ | 282.1490 | 282.1494 | -1.4 | 265.1223, 250.0998, 235.0762, 219.0824, 191.0863 | N-nornuciferine[ | + | + | |||||||||
34 | 9.71 | C38H40O18 | [M+H]+ | 785.2310 | 785.2293 | 2.2 | 665.1846, 447.1279, 429.1184, 411.1117, 327.0863, 177.0545 | 6‴-feruloylspinosin isomer[ | - | + | |||||||||
35 | 10.11 | C54H58NO25 | [M+HCOO]- | 1164.3208 | 1164.3196 | 1.0 | 1118.3135, 942.2715, 762.2023, 663.1707, 293.0443 | 6‴-O-(3-Glc-indole-acetyl)-6‴-feruloylspinosin or | - | + | |||||||||
isomer[ | |||||||||||||||||||
36 | 10.18 | C54H58NO25 | [M+HCOO]- | 1164.3210 | 1164.3196 | 1.2 | 1118.3145, 942.2654, 783.2103, 762.2061, 663.1730, 293.0453 | 6‴-O-(3-Glc-indole-acetyl)-6‴-feruloylspinosin[ | - | + | |||||||||
37 | 10.42 | C48H50O21 | [M-H]- | 961.2802 | 961.2766 | 3.75 | 943.2595, 931.2581, 307.0561 | 6‴-p-coumaroyl-6‴-sinapoyl spinosin[ | + | + | |||||||||
38 | 11.01 | C58H96O27 | [M+HCOO]- | 1269.6135 | 1269.6115 | 1.6 | 1223.6045, 919.4577, 787.4113, 625.3592, 479.3006, 255.2336 | protojujuboside B[ | + | + | |||||||||
39 | 11.56 | C53H86O22 | [M-H]- | 1073.5532 | 1073.5537 | -0.5 | 911.5039, 749.4492, 603.3906, 471.3479, 279.2314 | jujuboside Ⅰ[ | + | + | |||||||||
40 | 11.63 | C31H42N4O4 | [M+H]+ | 535.3268 | 535.3284 | -3.0 | 148.1116 | sanjoinine A[ | + | + | |||||||||
41 | 11.90 | C53H86O22 | [M+HCOO]- | 1119.5603 | 1119.5587 | 1.4 | 1073.5677, 749.4483, 603.3909, 471.3471, 279.2328 | jujuboside Ⅰ isomer[ | + | + | |||||||||
42 | 12.48 | C58H94O26 | [M+HCOO]- | 1251.6025 | 1251.6010 | 1.1 | 1073.5540, 911.5007, 749.4480, 603.3908, 471.3503 | jujuboside Ab | + | + | |||||||||
43 | 12.71 | C58H94O26 | [M+HCOO]- | 1251.6018 | 1251.6010 | 0.6 | 1073.5531, 911.4987, 749.4526, 279.2318 | jujuboside A isomer[ | + | + | |||||||||
44 | 12.94 | C52H84O21 | [M+HCOO]- | 1089.5496 | 1089.5482 | 1.3 | 1043.5425, 911.5007, 749.4480, 603.3908, 471.3448 | jujuboside Bb | + | + | |||||||||
45 | 13.10 | C55H86O24 | [M-H]- | 1129.5452 | 1129.5431 | 1.9 | 1085.5536, 1043.5443, 911.5009, 749.4488, 603.3905, | malonyl-jujuboside Ba,c | + | + | |||||||||
471.3534 | |||||||||||||||||||
46 | 13.36 | C54H86O22 | [M+HCOO]- | 1131.5596 | 1131.5587 | 0.8 | 1043.5497, 911.5013, 749.4485, 603.3876, 471.1332 | acetyl-jujuboside B[ | + | + | |||||||||
47 | 15.33 | C27H49O12P | [M-H]- | 595.2886 | 595.2883 | 0.5 | 595.2848, 279.2317, 241.0104 | 1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho- | + | + | |||||||||
(1'-myo-inositol)a,c | |||||||||||||||||||
48 | 15.98 | C43H79O13P | [M-H]- | 833.5173 | 833.5180 | -0.8 | 571.2925, 371.0077, 281.2468, 255.2321, 241.0103, 152.9950, | 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)- | - | + | |||||||||
96.9687 | glycero-3-phospho-(1'-myo-inositol) or isomera,c | ||||||||||||||||||
49 | 16.53 | C30H48O4 | [M-H]- | 471.3479 | 471.3474 | 1.1 | 471.3474, 279.2320, 183.0129 | alphitolic acid[ | + | + | |||||||||
50 | 17.74 | C30H46O4 | [M-H]- | 469.3318 | 469.3318 | 0 | 451.3236, 391.2265, 279.2319 | zizyberanalic acid[ | + | + | |||||||||
51 | 18.26 | C30H46O5 | [M-H]- | 485.3273 | 485.3267 | 1.2 | 439.3222, 423.3263 | ceanothic acid[ | + | + | |||||||||
52 | 18.73 | C30H46O4 | [M-H]- | 469.3320 | 469.3318 | 0.4 | 391.2245, 279.2321 | zizyberanalic acid isomer[ | + | + | |||||||||
53 | 18.94 | C27H53O12P | [M-H]- | 599.3203 | 599.3196 | 1.2 | 315.0501, 283.2631, 255.2322, 241.0107, 223.0011, 152.9950, | 1-octadecanoyl-sn-glycero-3-phospho-(1'-myo- | - | + | |||||||||
78.9684 | inositol)a,c | ||||||||||||||||||
54 | 21.70 | C30H48O3 | [M-H]- | 455.3525 | 455.3525 | 0 | 455.3525, 407.3291 | betulinic acidb | + | + | |||||||||
55 | 23.42 | C18H32O2 | [M-H]- | 279.2324 | 279.2324 | 0 | 279.2322 | linoleic acid[ | + | + | |||||||||
56 | 23.90 | C30H46O3 | [M-H]- | 453.3370 | 453.3369 | 0.2 | 325.1949, 293.1786, 279.2320, 255.2321 | betulonic acid[ | + | + | |||||||||
57 | 24.81 | C18H34O2 | [M-H]- | 281.2476 | 281.2481 | -1.8 | 281.2487 | oleic acid[ | + | + |
Table 1 Chemical constituents in seed coat and kernel of Ziziphi Spinosae Semen identified by UPLC-Q-TOF/MSE
No. | tR in | Formula | Precursor ion | Mass | Theoretical mass | Error/ 10-6 | Fragment ions (m/z) | Compound | Seed coat | Seed kernel | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2.25 | C16H18O9 | [M-H]- | 353.0867 | 353.0873 | -1.7 | 335.0876, 191.0549, 179.0344, 161.0211, 135.0441 | neochlorogenic acid[ | + | + | |||||||||
2 | 3.30 | C16H18O9 | [M-H]- | 353.0870 | 353.0873 | -0.9 | 191.0550, 179.0347, 161.0232, 85.0329 | chlorogenic acid[ | + | + | |||||||||
3 | 3.52 | C16H18O9 | [M-H]- | 353.0869 | 353.0873 | -1.1 | 191.0557, 179.0339, 173.0450, 161.0248, 155.0330, 135.0444, | cryptochlorogenic acid[ | + | + | |||||||||
93.0338 | |||||||||||||||||||
4 | 3.67 | C19H24NO3 | [M]+ | 314.1760 | 314.1756 | 1.3 | 314.1755, 269.1203, 237.0095, 211.1090, 175.0743, 145.0653, | magnocurarine isomer[ | + | + | |||||||||
116.9765, 107.0503 | |||||||||||||||||||
5 | 4.26 | C17H19NO3 | [M+H]+ | 286.1447 | 286.1443 | 1.4 | 286.1440, 269.1181, 237.0911, 209.0965, 191.0856, 175.0756, | aconitine[ | + | + | |||||||||
143.0495, 107.0496 | |||||||||||||||||||
6 | 4.66 | C20H26NO4 | [M]+ | 344.1860 | 344.1862 | -0.6 | 299.1278, 267.0997, 239.1145, 237.0904, 207.9867, 175.0752, | tembetarin[ | + | + | |||||||||
137.0577 | |||||||||||||||||||
7 | 4.73 | C27H30O15 | [M-H]- | 593.1514 | 593.1506 | 1.4 | 473.1082, 395.0771, 383.0767, 353.0657, 325.0708, 297.0758 | vicenin-Ⅱ[ | + | + | |||||||||
8 | 4.84 | C20H24NO4 | [M]+ | 342.1703 | 342.1705 | -0.6 | 297.1129, 282.0894, 265.0867, 237.0914, 219.0803, 58.0668 | magnoflorineb | + | + | |||||||||
9 | 5.51 | C19H24NO3 | [M]+ | 314.1761 | 314.1756 | 1.6 | 314.1755, 269.1185, 237.0928, 209.0956, 175.0746, 143.0493 | magnocurarine[ | + | + | |||||||||
10 | 6.00 | C42H48O23 | [M+H]+ | 921.2681 | 921.2665 | 1.7 | 759.2183, 741.1762, 639.1682, 447.1330, 429.1185, 411.1058, | 6‴-(4‴-O-glc)-vanilloylspinosin[ | - | + | |||||||||
381.0920, 351.0924, 327.0807, 151.0363 | |||||||||||||||||||
11 | 6.08 | C27H30O15 | [M+H]+ | 595.1649 | 595.1663 | -2.4 | 433.1125, 415.1020, 397.0916, 379.0811, 367.0818, 337.0724, | meloside A[ | - | + | |||||||||
313.0710, 283.0609 | |||||||||||||||||||
12 | 6.29 | C32H38O19 | [M+H]+ | 727.2081 | 727.2086 | -0.7 | 595.1814, 581.1440, 449.1064, 287.0556 | camelliaside B[ | + | + | |||||||||
13 | 6.40 | C28H32O15 | [M+H]+ | 609.1804 | 609.1819 | -2.5 | 447.1285, 429.1191, 411.1051, 393.0976, 351.0873, 327.0871, | isospinosin[ | + | + | |||||||||
297.0765, 285.0767 | |||||||||||||||||||
14 | 6.49 | C28H32O15 | [M+H]+ | 609.1813 | 609.1819 | -1.0 | 489.1479, 447.1290, 429.1180, 411.1070, 393.1081, 381.0967, | spinosinb | + | + | |||||||||
351.0864, 327.0868, 297.0757 | |||||||||||||||||||
15 | 6.56 | C21H20O10 | [M-H]- | 431.0972 | 431.0978 | -1.4 | 323.0573, 311.0557, 307.0622, 293.0428, 283.0594, 281.0456, | isovitexin[ | + | + | |||||||||
269.0444 | |||||||||||||||||||
16 | 6.67 | C27H30O15 | [M-H]- | 593.1511 | 593.1506 | 0.8 | 593.1526, 285.0394 | kaempferol-3-O-rutoside isomer[ | + | + | |||||||||
17 | 6.73 | C29H36O15 | [M-H]- | 623.1985 | 623.1976 | 1.4 | 461.1664, 179.0341, 161.0236 | acteoside[ | + | + | |||||||||
18 | 6.81 | C29H36O15 | [M-H]- | 623.1982 | 623.1976 | 1.0 | 461.0904, 179.0342, 161.0236 | isoacteoside[ | + | + | |||||||||
19 | 6.87 | C22H22O10 | [M+H]+ | 447.1292 | 447.1291 | 0.2 | 429.1295, 411.1142, 327.0872, 297.0773, 174.0549 | swertisin[ | + | + | |||||||||
20 | 7.29 | C25H24O12 | [M-H]- | 515.1195 | 515.1190 | 1.0 | 353.0880, 191.0553, 179.0340, 173.0448, 135.0443 | isochlorogenic acid B[ | + | + | |||||||||
21 | 7.40 | C27H30O15 | [M-H]- | 593.1508 | 593.1506 | 0.3 | 285.0388, 284.0316, 255.0291 | kaempferol-3-O-rutoside[ | - | + | |||||||||
22 | 7.53 | C25H24O12 | [M-H]- | 515.1190 | 515.1190 | 0 | 353.0858, 191.0552, 179.0340, 173.0458, 135.0439 | isochlorogenic acid A[ | + | + | |||||||||
23 | 7.70 | C44H49O22N | [M+H]+ | 944.2816 | 944.2824 | -0.9 | 944.2839, 824.2661, 447.1273, 429.1159, 327.0866, 297.1133 | 6‴-O-(3-Glc-indole-acetyl)spinosin or isomer[ | - | + | |||||||||
24 | 7.75 | C37H38O18 | [M+H]+ | 771.2140 | 771.2136 | 0.5 | 651.1650, 609.1619, 433.1139, 415.1023, 379.0705, 337.0701, | isovitexin-2″-O-(6-feruloyl)-glucopyranoside[ | + | + | |||||||||
313.0726, 177.0555 | |||||||||||||||||||
25 | 7.82 | C44H49O22N | [M+H]+ | 944.2815 | 944.2824 | 0.1 | 944.2797, 824.2675, 447.1271, 429.1161, 411.1082, 327.0849, | 6‴-O-(3-Glc-indole-acetyl)spinosin or isomer[ | - | + | |||||||||
297.0788 | |||||||||||||||||||
26 | 8.15 | C25H24O12 | [M-H]- | 515.1185 | 515.1190 | -1.0 | 353.0862, 191.0551, 179.0338, 173.0447, 135.0443 | isochlorogenic acid C[ | + | + | |||||||||
27 | 8.18 | C39H42O19 | [M+H]+ | 815.2397 | 815.2399 | -0.3 | 695.2109, 609.1945, 447.1345, 429.1194, 411.1042, 393.0956, | 6‴-sinapoylspinosin[ | - | + | |||||||||
327.0868, 297.0854, 207.0659, 163.0387 | |||||||||||||||||||
28 | 8.20 | C43H52O19 | [M+H]+ | 873.3188 | 873.3181 | 0.8 | 855.3101, 735.2551, 447.1412, 429.1191, 411.1068, 393.0933, | 6‴-dihydrophaseoylspinosin[ | - | + | |||||||||
351.0852, 327.0861, 247.1341, 207.0649, 163.0397 | |||||||||||||||||||
29 | 8.30 | C37H38O17 | [M+H]+ | 755.2174 | 755.2187 | -1.7 | 635.1722, 609.1754, 447.1285, 429.1180, 351.0857, 327.0863, | 6‴-p-coumaloylspinosin[ | - | + | |||||||||
309.0979, 147.0442 | |||||||||||||||||||
30 | 8.39 | C38H40O18 | [M+H]+ | 785.2289 | 785.2293 | -0.5 | 665.1870, 609.1771, 447.1184, 429.1184, 411.1092, 393.0977, | 6‴-feruloylspinosinb | + | + | |||||||||
381.0981, 351.0871, 327.0869, 207.0765, 177.0551 | |||||||||||||||||||
31 | 8.74 | C44H49O22N | [M+H]+ | 944.2810 | 944.2824 | -1.5 | 944.2797, 782.2302, 764.2184, 489.1389, 393.0977, 327.0861 | 3‴-(N-β-D-Glucopyranosyl)-2‴,3‴-dihydro-2‴- | - | + | |||||||||
oxo-indol-3‴-yl-acetate spinosin or isomer[ | |||||||||||||||||||
32 | 8.84 | C44H49O22N | [M+H]+ | 944.2811 | 944.2824 | -1.4 | 944.2799, 782.2269, 764.2170, 602.1631, 489.1395, 393.0974, | 6‴-(N-β-D-glucopyranosyl)-2‴,3‴-dihydro-2‴- | - | + | |||||||||
327.0861 | oxo-indol-3‴-yl-acetate spinosin or isomer[ | ||||||||||||||||||
33 | 9.37 | C18H19NO2 | [M+H]+ | 282.1490 | 282.1494 | -1.4 | 265.1223, 250.0998, 235.0762, 219.0824, 191.0863 | N-nornuciferine[ | + | + | |||||||||
34 | 9.71 | C38H40O18 | [M+H]+ | 785.2310 | 785.2293 | 2.2 | 665.1846, 447.1279, 429.1184, 411.1117, 327.0863, 177.0545 | 6‴-feruloylspinosin isomer[ | - | + | |||||||||
35 | 10.11 | C54H58NO25 | [M+HCOO]- | 1164.3208 | 1164.3196 | 1.0 | 1118.3135, 942.2715, 762.2023, 663.1707, 293.0443 | 6‴-O-(3-Glc-indole-acetyl)-6‴-feruloylspinosin or | - | + | |||||||||
isomer[ | |||||||||||||||||||
36 | 10.18 | C54H58NO25 | [M+HCOO]- | 1164.3210 | 1164.3196 | 1.2 | 1118.3145, 942.2654, 783.2103, 762.2061, 663.1730, 293.0453 | 6‴-O-(3-Glc-indole-acetyl)-6‴-feruloylspinosin[ | - | + | |||||||||
37 | 10.42 | C48H50O21 | [M-H]- | 961.2802 | 961.2766 | 3.75 | 943.2595, 931.2581, 307.0561 | 6‴-p-coumaroyl-6‴-sinapoyl spinosin[ | + | + | |||||||||
38 | 11.01 | C58H96O27 | [M+HCOO]- | 1269.6135 | 1269.6115 | 1.6 | 1223.6045, 919.4577, 787.4113, 625.3592, 479.3006, 255.2336 | protojujuboside B[ | + | + | |||||||||
39 | 11.56 | C53H86O22 | [M-H]- | 1073.5532 | 1073.5537 | -0.5 | 911.5039, 749.4492, 603.3906, 471.3479, 279.2314 | jujuboside Ⅰ[ | + | + | |||||||||
40 | 11.63 | C31H42N4O4 | [M+H]+ | 535.3268 | 535.3284 | -3.0 | 148.1116 | sanjoinine A[ | + | + | |||||||||
41 | 11.90 | C53H86O22 | [M+HCOO]- | 1119.5603 | 1119.5587 | 1.4 | 1073.5677, 749.4483, 603.3909, 471.3471, 279.2328 | jujuboside Ⅰ isomer[ | + | + | |||||||||
42 | 12.48 | C58H94O26 | [M+HCOO]- | 1251.6025 | 1251.6010 | 1.1 | 1073.5540, 911.5007, 749.4480, 603.3908, 471.3503 | jujuboside Ab | + | + | |||||||||
43 | 12.71 | C58H94O26 | [M+HCOO]- | 1251.6018 | 1251.6010 | 0.6 | 1073.5531, 911.4987, 749.4526, 279.2318 | jujuboside A isomer[ | + | + | |||||||||
44 | 12.94 | C52H84O21 | [M+HCOO]- | 1089.5496 | 1089.5482 | 1.3 | 1043.5425, 911.5007, 749.4480, 603.3908, 471.3448 | jujuboside Bb | + | + | |||||||||
45 | 13.10 | C55H86O24 | [M-H]- | 1129.5452 | 1129.5431 | 1.9 | 1085.5536, 1043.5443, 911.5009, 749.4488, 603.3905, | malonyl-jujuboside Ba,c | + | + | |||||||||
471.3534 | |||||||||||||||||||
46 | 13.36 | C54H86O22 | [M+HCOO]- | 1131.5596 | 1131.5587 | 0.8 | 1043.5497, 911.5013, 749.4485, 603.3876, 471.1332 | acetyl-jujuboside B[ | + | + | |||||||||
47 | 15.33 | C27H49O12P | [M-H]- | 595.2886 | 595.2883 | 0.5 | 595.2848, 279.2317, 241.0104 | 1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho- | + | + | |||||||||
(1'-myo-inositol)a,c | |||||||||||||||||||
48 | 15.98 | C43H79O13P | [M-H]- | 833.5173 | 833.5180 | -0.8 | 571.2925, 371.0077, 281.2468, 255.2321, 241.0103, 152.9950, | 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)- | - | + | |||||||||
96.9687 | glycero-3-phospho-(1'-myo-inositol) or isomera,c | ||||||||||||||||||
49 | 16.53 | C30H48O4 | [M-H]- | 471.3479 | 471.3474 | 1.1 | 471.3474, 279.2320, 183.0129 | alphitolic acid[ | + | + | |||||||||
50 | 17.74 | C30H46O4 | [M-H]- | 469.3318 | 469.3318 | 0 | 451.3236, 391.2265, 279.2319 | zizyberanalic acid[ | + | + | |||||||||
51 | 18.26 | C30H46O5 | [M-H]- | 485.3273 | 485.3267 | 1.2 | 439.3222, 423.3263 | ceanothic acid[ | + | + | |||||||||
52 | 18.73 | C30H46O4 | [M-H]- | 469.3320 | 469.3318 | 0.4 | 391.2245, 279.2321 | zizyberanalic acid isomer[ | + | + | |||||||||
53 | 18.94 | C27H53O12P | [M-H]- | 599.3203 | 599.3196 | 1.2 | 315.0501, 283.2631, 255.2322, 241.0107, 223.0011, 152.9950, | 1-octadecanoyl-sn-glycero-3-phospho-(1'-myo- | - | + | |||||||||
78.9684 | inositol)a,c | ||||||||||||||||||
54 | 21.70 | C30H48O3 | [M-H]- | 455.3525 | 455.3525 | 0 | 455.3525, 407.3291 | betulinic acidb | + | + | |||||||||
55 | 23.42 | C18H32O2 | [M-H]- | 279.2324 | 279.2324 | 0 | 279.2322 | linoleic acid[ | + | + | |||||||||
56 | 23.90 | C30H46O3 | [M-H]- | 453.3370 | 453.3369 | 0.2 | 325.1949, 293.1786, 279.2320, 255.2321 | betulonic acid[ | + | + | |||||||||
57 | 24.81 | C18H34O2 | [M-H]- | 281.2476 | 281.2481 | -1.8 | 281.2487 | oleic acid[ | + | + |
Fig. 2 PCA score chart of seed coat and kernel in negative ion mode QC: quality control; C: seed coat; K: seed kernel. PCA: principal component analysis.
Fig. 3 OPLS-DA score chart of seed coat and kernel in negative ion mode S5 samples near the median values of the two groups of seed coat and kernel. OPLS-DA: orthogonal partial least squares-discriminant analysis.
Fig. 4 S-plot of seed coat and kernel VIP: variable importance in projection. Hollow circles: the screened differential components; black squares: components with no significant differences. The numbers in Fig. 4 hereby are consistent with those in Table 1.
No. | Peak No.1) | tR/min | Formula | Compound2) | VIP | Main presence part |
---|---|---|---|---|---|---|
1 | 54 | 21.70 | C30H48O3 | betulinic acid | 31.85 | seed coat |
2 | 14 | 6.49 | C28H32O15 | spinosin | 16.92 | seed kernel |
3 | 42 | 12.48 | C58H94O26 | jujuboside A | 16.85 | seed kernel |
4 | 30 | 8.39 | C38H40O18 | 6‴-feruloylspinosin | 14.55 | seed kernel |
5 | 56 | 23.90 | C30H46O3 | betulonic acid | 13.06 | seed coat |
6 | 49 | 16.53 | C30H48O4 | alphitolic acid | 12.05 | seed coat |
7 | 44 | 12.94 | C52H84O21 | jujuboside B | 10.75 | seed kernel |
8 | 47 | 15.33 | C27H49O12P | 1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho-(1'-myo-inositol) | 10.07 | seed kernel |
9 | 45 | 13.10 | C55H86O24 | malonyl-jujuboside B | 9.77 | seed kernel |
10 | 48 | 15.98 | C43H79O13P | 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phospho- | 8.81 | seed kernel |
(1'-myo-inositol) or isomer | ||||||
11 | 8 | 4.84 | C20H24NO4 | magnoflorine | 7.99 | seed kernel |
12 | 29 | 8.30 | C37H38O17 | 6‴-p-coumaloylspinosin | 7.18 | seed kernel |
13 | 39 | 11.56 | C53H86O22 | jujuboside Ⅰ | 6.49 | seed coat |
14 | 35 | 10.11 | C54H58NO25 | 6‴-O-(3-Glc-indole-acetyl)-6‴-feruloylspinosin | 6.22 | seed kernel |
15 | 11 | 6.08 | C27H30O15 | meloside A | 5.78 | seed kernel |
16 | 32 | 8.84 | C44H49O22N | 6‴-(N-β-D-glucopyranosyl)-2‴,3‴-dihydro-2‴-oxo-indol-3‴-yl- | 5.66 | seed kernel |
acetate spinosin or isomer | ||||||
17 | 13 | 6.40 | C28H32O15 | isospinosin | 5.07 | seed kernel |
Table 2 Differential compounds for the seed coat and kernel of Ziziphi Spinosae Semen
No. | Peak No.1) | tR/min | Formula | Compound2) | VIP | Main presence part |
---|---|---|---|---|---|---|
1 | 54 | 21.70 | C30H48O3 | betulinic acid | 31.85 | seed coat |
2 | 14 | 6.49 | C28H32O15 | spinosin | 16.92 | seed kernel |
3 | 42 | 12.48 | C58H94O26 | jujuboside A | 16.85 | seed kernel |
4 | 30 | 8.39 | C38H40O18 | 6‴-feruloylspinosin | 14.55 | seed kernel |
5 | 56 | 23.90 | C30H46O3 | betulonic acid | 13.06 | seed coat |
6 | 49 | 16.53 | C30H48O4 | alphitolic acid | 12.05 | seed coat |
7 | 44 | 12.94 | C52H84O21 | jujuboside B | 10.75 | seed kernel |
8 | 47 | 15.33 | C27H49O12P | 1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho-(1'-myo-inositol) | 10.07 | seed kernel |
9 | 45 | 13.10 | C55H86O24 | malonyl-jujuboside B | 9.77 | seed kernel |
10 | 48 | 15.98 | C43H79O13P | 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phospho- | 8.81 | seed kernel |
(1'-myo-inositol) or isomer | ||||||
11 | 8 | 4.84 | C20H24NO4 | magnoflorine | 7.99 | seed kernel |
12 | 29 | 8.30 | C37H38O17 | 6‴-p-coumaloylspinosin | 7.18 | seed kernel |
13 | 39 | 11.56 | C53H86O22 | jujuboside Ⅰ | 6.49 | seed coat |
14 | 35 | 10.11 | C54H58NO25 | 6‴-O-(3-Glc-indole-acetyl)-6‴-feruloylspinosin | 6.22 | seed kernel |
15 | 11 | 6.08 | C27H30O15 | meloside A | 5.78 | seed kernel |
16 | 32 | 8.84 | C44H49O22N | 6‴-(N-β-D-glucopyranosyl)-2‴,3‴-dihydro-2‴-oxo-indol-3‴-yl- | 5.66 | seed kernel |
acetate spinosin or isomer | ||||||
17 | 13 | 6.40 | C28H32O15 | isospinosin | 5.07 | seed kernel |
Fig. 5 UPLC-CAD chromatograms of 100 μg/mL mixed standards (a)without and (b)with inverse gradient compensation 1. magnoflorine; 2. spinosin; 3. 6?-feruloylspinosin; 4. jujuboside A; 5. jujuboside B; 6. betulinic acid.
Mass concentration/(μg/mL) | fMagnoflorine | fSpinosin | f6‴-Feruloylspinosin | fJujuboside A | fJujuboside B | fBetulinic acid | RSD/% |
---|---|---|---|---|---|---|---|
100 | 0.005242 | 0.005262 | 0.005430 | 0.005395 | 0.005767 | 0.006391 | 7.87 |
75 | 0.004873 | 0.005108 | 0.005215 | 0.005203 | 0.00556 | 0.006309 | 9.43 |
50 | 0.005095 | 0.005231 | 0.005323 | 0.005534 | 0.005833 | 0.005757 | 5.41 |
25 | 0.004915 | 0.005239 | 0.005250 | 0.005268 | 0.005787 | 0.005812 | 6.53 |
10 | 0.004299 | 0.005059 | 0.005099 | 0.005519 | 0.005632 | 0.00542 | 9.37 |
Mean | 0.004885 | 0.005180 | 0.005264 | 0.005384 | 0.005716 | 0.005938 | 7.04 |
Table 3 Response factors (f) of each standard with different concentrations after inverse gradient compensation
Mass concentration/(μg/mL) | fMagnoflorine | fSpinosin | f6‴-Feruloylspinosin | fJujuboside A | fJujuboside B | fBetulinic acid | RSD/% |
---|---|---|---|---|---|---|---|
100 | 0.005242 | 0.005262 | 0.005430 | 0.005395 | 0.005767 | 0.006391 | 7.87 |
75 | 0.004873 | 0.005108 | 0.005215 | 0.005203 | 0.00556 | 0.006309 | 9.43 |
50 | 0.005095 | 0.005231 | 0.005323 | 0.005534 | 0.005833 | 0.005757 | 5.41 |
25 | 0.004915 | 0.005239 | 0.005250 | 0.005268 | 0.005787 | 0.005812 | 6.53 |
10 | 0.004299 | 0.005059 | 0.005099 | 0.005519 | 0.005632 | 0.00542 | 9.37 |
Mean | 0.004885 | 0.005180 | 0.005264 | 0.005384 | 0.005716 | 0.005938 | 7.04 |
Fig. 6 UPLC-CAD semi quantitative fingerprint chromatograms of seed coat and kernel of sample S5 1. magnoflorine; 2. spinosin; 3. 6?-feruloylspinosin; 4. jujuboside A; 5. jujuboside B; 6. malony-jujuboside B; 7. alphitolic acid; 8. linoleic acid; 9. betulinic acid; 10. oleic acid.
|
[1] | LUO Yun, GENG Ningbo, CHEN Shuangshuang, CHENG Lin, ZHANG Haijun, CHEN Jiping. Metabolomic interference induced by short-chain chlorinated paraffins in human normal hepatic cells [J]. Chinese Journal of Chromatography, 2024, 42(2): 176-184. |
[2] | SONG Yuanyuan, QI Zenghua, CAI Zongwei. Application of multiomics mass spectrometry in the research of chemical exposome [J]. Chinese Journal of Chromatography, 2024, 42(2): 120-130. |
[3] | MA Chao, NI Hongxing, QI Yulin. Chemical diversity of dissolved organic matter revealed by ultra performance liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry [J]. Chinese Journal of Chromatography, 2023, 41(8): 662-672. |
[4] | CAO Qinling, ZHAO Xiaodan, SHEN Guobin, WANG Zhuqin, ZHANG Hongyang, ZHANG Min, HU Ping. Fingerprint of sophorolipids based on ultra-high performance liquid chromatography-charged aerosol detection [J]. Chinese Journal of Chromatography, 2023, 41(8): 722-729. |
[5] | YANG Zhe, LYU Jianxia, WU Yidi, JIANG Liwei, LI Dongmei. Simultaneous determination of five indole/indazole amide-based synthetic cannabinoids in electronic cigarette oil by ultra performance liquid chromatography [J]. Chinese Journal of Chromatography, 2023, 41(7): 602-609. |
[6] | CHEN Jinnan, WANG Meng, DONG Zemin, YE Jin, LI Li, WU Yu, LIU Hongmei, WANG Songxue. Determination of four aflatoxins in feeds by high throughput automated immunoaffinity magnetic beads purification-ultra performance liquid chromatography [J]. Chinese Journal of Chromatography, 2023, 41(6): 504-512. |
[7] | ZOU Xiaowei, LIU Xing, ZHANG Jianming. Advances in thin layer chromatography coupled with mass spectrometry technology [J]. Chinese Journal of Chromatography, 2023, 41(1): 24-36. |
[8] | CHI Zhongmei, YANG Li. Advances in chiral separation and analysis by capillary electrophoresis-mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(6): 509-519. |
[9] | LI Yangjie, HUANG Jiaying, FANG Jihui, HUANG Zhiye. Fast screening and confirmation of 73 common prohibited compounds in cosmetics by ultra performance liquid chromatography-quadrupole-time-of-flight high resolution mass spectrometry [J]. Chinese Journal of Chromatography, 2022, 40(5): 433-442. |
[10] | CHENG Qian, JIA Daihui, ZHANG Bohui, XU Junyan, SHAO Zhe, HUANG Yingfeng, ZOU Xun. Analysis of glycan ratio of Chinese hamster ovary cell-cetuximab antigen-binding segment via rapid enzyme digestion with endo-β-N-acetylglucosaminidase F [J]. Chinese Journal of Chromatography, 2022, 40(2): 175-181. |
[11] | ZHANG Han, LIAO Xu, WEI Lai, ZHANG Zixing, REN Hongyun, ZHANG Xian. Design and application of online derivatization device for polar organics on atmospheric particulate filter [J]. Chinese Journal of Chromatography, 2022, 40(1): 100-106. |
[12] | GUO Xiujie, LI Haoqiu, FENG Haotian, QI Huawen, ZHANG Lu, XU Wei, WU Yanjuan, WANG Chaoran, LIANG Xinmiao. Quality analysis of Ziziphi Spinosae Semen extracts based on high performance liquid chromatography quantitative fingerprint and ultra-high performance liquid chromatography-tandem mass spectrometry quantification [J]. Chinese Journal of Chromatography, 2021, 39(9): 989-997. |
[13] | SHENG Qianying, ZHOU Yang, ZHAO Zhiquan, WANG Yaohui, LI Weicheng, KE Yanxiong, LAN Minbo, QING Guangyan, LIANG Xinmiao. Covalent organic framework functional materials and their applications in glycopeptide enrichment [J]. Chinese Journal of Chromatography, 2021, 39(6): 588-598. |
[14] | QU Li, GU Shuqing, ZHANG Jiaqi, ZHAO Chaomin, DENG Xiaojun. Determination of 18 amino acids in three different kinds of milk powder by ultra performance liquid chromatography coupled with pre-column derivatization [J]. Chinese Journal of Chromatography, 2021, 39(5): 472-477. |
[15] | WU Qiong, SUI Xintong, TIAN Ruijun. Advances in high-throughput proteomic analysis [J]. Chinese Journal of Chromatography, 2021, 39(2): 112-117. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 156
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 279
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||